Function of MLL in transcription regulation
Function of MLL in transcription regulation
批准号:
10393016
负责人:
Yali Dou
金额:
$35.09万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2024-04-30
关键词:
3-DimensionalAgingArchitectureBindingCCCTC-binding factorCellsChromatinCuesDataDefectDepositionDevelopmentDevelopmental Therapeutics ProgramDistalEmbryonic DevelopmentEnhancersEnzymesEpiblastEpigenetic ProcessFamilyFoundationsGene Expression RegulationGenesGeneticGenetic ModelsGenetic TranscriptionGenomeGoalsHistone H3HistonesHumanImmune System DiseasesIn VitroInfectionInflammationInner Cell MassLinkMLL geneMalignant - descriptorMalignant NeoplasmsMammalian CellMammalsMediatingMedicineMethylationMethyltransferaseMixed-Lineage LeukemiaModelingMolecularMutationNatural regenerationNucleic Acid Regulatory SequencesPlayPost-Translational Protein ProcessingProcessRecording of previous eventsRecurrenceRegenerative MedicineRegulationRegulatory ElementReportingResearchRoleSET DomainScienceSyndromeTestingTotipotentTranscriptional ActivationTranscriptional RegulationWorkcell typedevelopmental diseaseembryo stage 2epigenetic regulationepigenomicsextracellularhistone methyltransferasehistone modificationhuman diseasein vivoinsightloss of functionmembernovelpluripotencyprogramspromotersmall molecule inhibitorstem cell biologystem cell differentiationstem cellstranscription factor
中文摘要
项目摘要
细胞特性由整合细胞信息的细胞特异性转录电路决定
历史和细胞外线索。它通常涉及染色质水平的多层调控。
表观基因组学研究已经确定了与转录相关的保守染色质特征
激活。其中之一是组蛋白H3 K4甲基化在顺式调节元件上的富集化
包括基因启动子和增强子。这些调控序列通常起着如下作用
具有意想不到的复杂性和动态性的集成转录因子结合平台
在不同的细胞类型中。在哺乳动物中,H3K4甲基化是由混合血统沉积的
白血病(MLL)酶家族。每个MLL都发挥着基本的、非冗余的功能
在胚胎发育过程中。据报道,在许多人类中存在MLL的反复突变
疾病包括发育障碍、癌症和免疫性疾病。然而,
每个MLL的具体职能和监管问题仍然存在。目前也不清楚是否
MLLS的酶活性在转录调控中起着不可缺少的作用。在这里,我们将
研究MLL家族的创始成员MLL1在细胞命运决定中的作用
并使用强大的干细胞分化和重新编程模型进行转化。我们将解剖
包括催化集结构域在内的每个MLL1结构域在细胞命运中的基本功能
决心。我们还将研究MLL1调节转录和
它可能与其他MLL有何不同。我们的研究将为基础研究提供新的见解
多能性的机制和基因调控。
英文摘要
Project Summary
Cell identity is determined by cell specific transcription circuitry that integrate information of cell
history and extracellular cues. It often involves multilayered regulation at the level of chromatin.
Epigenomic studies have identified conserved chromatin features associated with transcription
activation. Among them is enrichment of histone H3 K4 methylation at cis-regulatory elements
including gene promoters and enhancers. These regulatory sequences often function as
integrated transcription factor binding platforms that have unexpected complexity and dynamics
in different cell types. In mammal, H3 K4 methylation is deposited by the mixed lineage
leukemia (MLL) family of enzymes. Each MLL plays an essential and non-redundant function
during embryonic development. Recurrent mutations in MLLs are reported in many human
diseases including developmental disorders, cancers and immunological diseases. However,
questions of specific function and regulation of each MLL remain. It is also unclear whether the
enzymatic activity of MLLs has any obligatory role in transcription regulation. Here we will
examine the function of MLL1, the founding member of the MLL family, in cell fate determination
and transition using a robust stem cell differentiation and reprograming model. We will dissect
the essential function of each MLL1 domain including the catalytic SET domain in cell fate
determination. We will also examine the mechanism by which MLL1 regulates transcription and
how it may be distinct from other MLLs. Our study will provide novel insights into basic
mechanisms of pluripotency and gene regulation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhancer Dysregulation in AML
-
批准号:10350708
-
项目类别:
-
资助金额:$54.86万
-
财政年份:2019
-
负责人:Yali Dou
-
依托单位:
Enhancer Dysregulation in AML
-
批准号:10238176
-
项目类别:
-
资助金额:$55.98万
-
财政年份:2019
-
负责人:Yali Dou
-
依托单位:
Enhancer Dysregulation in AML
-
批准号:9882974
-
项目类别:
-
资助金额:$20.65万
-
财政年份:2019
-
负责人:Yali Dou
-
依托单位:
Enhancer Dysregulation in AML
-
批准号:10199697
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2019
-
负责人:Yali Dou
-
依托单位:
Enhancer Dysregulation in AML
-
批准号:10582664
-
项目类别:
-
资助金额:$54.86万
-
财政年份:2019
-
负责人:Yali Dou
-
依托单位:
PRDM16 function in neural development
-
批准号:9340299
-
项目类别:
-
资助金额:$42.26万
-
财政年份:2016
-
负责人:Yali Dou
-
依托单位:
PRDM16 function in neural development
-
批准号:9767868
-
项目类别:
-
资助金额:$42.26万
-
财政年份:2016
-
负责人:Yali Dou
-
依托单位:
Chromatin replication control by protein ubiquitylation
-
批准号:8957568
-
项目类别:
-
资助金额:$16.86万
-
财政年份:2015
-
负责人:Yali Dou
-
依托单位:
Targeting MLL3 histone methyltransferase
-
批准号:9054816
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2015
-
负责人:Yali Dou
-
依托单位:
Targeting MLL3 histone methyltransferase
-
批准号:9241886
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2015
-
负责人:Yali Dou
-
依托单位:
Targeting the MLL-WDR5 protein-protein interaction
-
批准号:8536046
-
项目类别:
-
资助金额:$46.82万
-
财政年份:2013
-
负责人:Yali Dou
-
依托单位:
Targeting the MLL-WDR5 protein-protein interaction
-
批准号:8650277
-
项目类别:
-
资助金额:$45.42万
-
财政年份:2013
-
负责人:Yali Dou
-
依托单位:
Cytokine-induced epigenetic changes during chronic lung disease
-
批准号:8435573
-
项目类别:
-
资助金额:$53.73万
-
财政年份:2013
-
负责人:Yali Dou
-
依托单位:
Cytokine-induced epigenetic changes during chronic lung disease
-
批准号:8681507
-
项目类别:
-
资助金额:$55.31万
-
财政年份:2013
-
负责人:Yali Dou
-
依托单位:
Targeting the MLL-WDR5 protein-protein interaction
-
批准号:9041548
-
项目类别:
-
资助金额:$45.15万
-
财政年份:2013
-
负责人:Yali Dou
-
依托单位:
Targeting the MLL-WDR5 protein-protein interaction
-
批准号:8825471
-
项目类别:
-
资助金额:$46.82万
-
财政年份:2013
-
负责人:Yali Dou
-
依托单位:
Cytokine-induced epigenetic changes during chronic lung disease
-
批准号:8849491
-
项目类别:
-
资助金额:$55.59万
-
财政年份:2013
-
负责人:Yali Dou
-
依托单位:
Epigenetic regulation of transcription by mixed lineage leukemia protein MLL1
-
批准号:8225227
-
项目类别:
-
资助金额:$28.77万
-
财政年份:2009
-
负责人:Yali Dou
-
依托单位:
Epigenetic regulation of transcription by mixed lineage leukemia protein MLL1
-
批准号:7786997
-
项目类别:
-
资助金额:$29.06万
-
财政年份:2009
-
负责人:Yali Dou
-
依托单位:
Function of MLL in transcription regulation
-
批准号:10611964
-
项目类别:
-
资助金额:$35.09万
-
财政年份:2009
-
负责人:Yali Dou
-
依托单位:
海外基金